BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 19647617)

  • 1. Health-related quality of life and cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy.
    McQuellon R; Duckworth KE
    Curr Probl Cancer; 2009; 33(3):203-18. PubMed ID: 19647617
    [No Abstract]   [Full Text] [Related]  

  • 2. Appendix A: hyperthermic intraperitoneal chemotherapy: a perfusionist's perspective.
    Evans GS; Charles DJ
    Curr Probl Cancer; 2009; 33(3):219-26. PubMed ID: 19647618
    [No Abstract]   [Full Text] [Related]  

  • 3. Quality of life after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface malignancies.
    Piso P; Glockzin G; von Breitenbuch P; Popp FC; Dahlke MH; Schlitt HJ; Nissan A
    J Surg Oncol; 2009 Sep; 100(4):317-20. PubMed ID: 19697438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of quality of life of patients submitted to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinosis of gastrointestinal and ovarian origin and identification of factors influencing outcome.
    Macrì A; Maugeri I; Trimarchi G; Caminiti R; Saffioti MC; Incardona S; Sinardi A; Irato S; Altavilla G; Adamo V; Versaci A; Famulari C
    In Vivo; 2009; 23(1):147-50. PubMed ID: 19368140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant mixed mesodermal tumours with peritoneal dissemination.
    de Bree E; Romanos J; Relakis K; Tsiftsis DD
    Eur J Surg Oncol; 2005 Feb; 31(1):111-2. PubMed ID: 15642436
    [No Abstract]   [Full Text] [Related]  

  • 6. Appendix B: nursing care of the HIPEC patient.
    Wooten L
    Curr Probl Cancer; 2009; 33(3):227-37. PubMed ID: 19647619
    [No Abstract]   [Full Text] [Related]  

  • 7. Results of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal cancer.
    Glockzin G; Ghali N; Lang SA; Schlitt HJ; Piso P
    J Surg Oncol; 2009 Sep; 100(4):306-10. PubMed ID: 19697436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperthermic intraperitoneal chemotherapy in advanced gastric cancer: the end of skepticism?
    Glehen O; Gilly FN; Cotte E
    Ann Surg Oncol; 2011 Jun; 18(6):1524-6. PubMed ID: 21384246
    [No Abstract]   [Full Text] [Related]  

  • 9. Safety of gastric resections during cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis.
    Piso P; Slowik P; Popp F; Dahlke MH; Glockzin G; Schlitt HJ
    Ann Surg Oncol; 2009 Aug; 16(8):2188-94. PubMed ID: 19408049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Learning curve in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Moradi BN; Esquivel J
    J Surg Oncol; 2009 Sep; 100(4):293-6. PubMed ID: 19697425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hidden opportunities in cytoreductive surgery for peritoneal carcinomatosis of colorectal origin.
    Chang GJ; Lambert LA
    Ann Surg Oncol; 2008 Nov; 15(11):2993-5. PubMed ID: 18787903
    [No Abstract]   [Full Text] [Related]  

  • 12. Laparoscopic hyperthermic intraperitoneal peroperative chemotherapy (HIPEC) in the management of refractory malignant ascites: A multi-institutional retrospective analysis in 52 patients.
    Valle M; Van der Speeten K; Garofalo A
    J Surg Oncol; 2009 Sep; 100(4):331-4. PubMed ID: 19697441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of life and nutritional assessment in peritoneal surface malignancy (PSM): recommendations for care.
    McQuellon R; Gavazzi C; Piso P; Swain D; Levine E
    J Surg Oncol; 2008 Sep; 98(4):300-5. PubMed ID: 18726903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hyperthermic intrapleural chemotherapy--another modality for the treatment of malignant pleural neoplasia].
    Galie N; Tabacu E
    Pneumologia; 2008; 57(4):246-7. PubMed ID: 19186688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term results of cytoreduction and HIPEC followed by systemic chemotherapy.
    Verwaal VJ
    Cancer J; 2009; 15(3):212-5. PubMed ID: 19556907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reported impact of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy on systemic toxicity.
    Sugarbaker PH
    Ann Surg Oncol; 2008 Jun; 15(6):1800-1; author reply 1802-3. PubMed ID: 18196342
    [No Abstract]   [Full Text] [Related]  

  • 17. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface malignancy: overview and rationale.
    Shen P; Stewart JH; Levine EA
    Curr Probl Cancer; 2009; 33(3):125-41. PubMed ID: 19647612
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hyperthermic therapy of cancer].
    Egawa S
    Gan No Rinsho; 1989 Jan; Spec No():34-41. PubMed ID: 2915485
    [No Abstract]   [Full Text] [Related]  

  • 19. Indications and patient selection for cytoreductive surgery and perioperative intraperitoneal chemotherapy.
    González-Moreno S; Ortega-Pérez G; González-Bayón L
    J Surg Oncol; 2009 Sep; 100(4):287-92. PubMed ID: 19697424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytoreductive surgery plus intraperitoneal chemohyperthermia in patients with colorectal cancer at high risk for local-regional recurrence.
    Lefevre JH; Elias DM
    Cancer J; 2009; 15(3):200-3. PubMed ID: 19556905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.